Clinical Trials Logo

Clinical Trial Summary

This study was conducted to investigate the effects of daily supplementation of GTB1 on decrease of body fat.


Clinical Trial Description

This study was a 12 week, randomized, double-blind, placebo-controlled human trial. 100 subjects were randomly divided into GTB1 group and placebo group. It is to evaluate the changes in the displayed evaluation items when taking GTB1 once a day, in comparison with taking a placebo. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06422013
Study type Interventional
Source Amorepacific Corporation
Contact
Status Completed
Phase N/A
Start date October 28, 2022
Completion date December 8, 2023

See also
  Status Clinical Trial Phase
Completed NCT03409705 - Effect of Skate Skin Extract on Body Fat in Overweight Adults N/A
Recruiting NCT04023864 - Efficacy and Safety of Platycodon Grandiflorus Extract(GCWB107) on Decrease of Body Fat N/A
Completed NCT04418713 - Active Videogames Against Obesity in Children N/A
Recruiting NCT05869799 - Effect of Vigiis 101 Lactic Acid Bacteria Powder on Body Weight and Body Fat in Overweight Participants N/A
Completed NCT01360619 - Clinical Study About Fat Measurement on Multifunction Keito by Comparison Versus Its Predicate K014009 N/A
Completed NCT03433417 - Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat N/A
Completed NCT04569253 - Multi-Center Pivotal Study of Radiofrequency Device N/A
Completed NCT01138774 - Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) in Human Obesity N/A
Terminated NCT04584099 - Multi-Center Traditional Feasibility Study of Radiofrequency Device N/A
Completed NCT01665118 - The Trusculpt (Radio Frequency) Device For Thigh Circumference Reduction N/A
Completed NCT03433430 - Multi-Center Pilot Study of truSculpt Device N/A